Metro Healthcare Indonesia Past Earnings Performance
Past criteria checks 0/6
Metro Healthcare Indonesia's earnings have been declining at an average annual rate of -53.7%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 9.2% per year.
Key information
-53.7%
Earnings growth rate
149.6%
EPS growth rate
| Healthcare Industry Growth | 14.1% |
| Revenue growth rate | 9.2% |
| Return on equity | -3.6% |
| Net Margin | -45.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Metro Healthcare Indonesia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 242,681 | -110,920 | 116,897 | 0 |
| 30 Sep 23 | 213,825 | -104,612 | 128,321 | 0 |
| 30 Jun 23 | 216,489 | -81,944 | 127,167 | 0 |
| 31 Mar 23 | 219,589 | -104,203 | 140,298 | 0 |
| 31 Dec 22 | 260,426 | -93,544 | 146,826 | 0 |
| 30 Sep 22 | 230,153 | -92,420 | 134,030 | 0 |
| 30 Jun 22 | 257,336 | -61,350 | 132,219 | 0 |
| 31 Mar 22 | 278,751 | -25,135 | 127,914 | 0 |
| 31 Dec 21 | 290,934 | 6,099 | 121,607 | 0 |
| 30 Sep 21 | 289,799 | 21,958 | 128,494 | 0 |
| 30 Jun 21 | 258,201 | 23,746 | 125,317 | 0 |
| 31 Mar 21 | 234,686 | 24,829 | 118,894 | 0 |
| 31 Dec 20 | 216,296 | 14,313 | 113,605 | 0 |
| 30 Sep 20 | 198,330 | 8,811 | 97,615 | 0 |
| 30 Jun 20 | 214,832 | -3,907 | 95,010 | 0 |
| 31 Mar 20 | 186,776 | -17,929 | 79,605 | 0 |
| 31 Dec 19 | 154,077 | -24,205 | 64,439 | 0 |
| 31 Dec 18 | 87,209 | -27,487 | 38,279 | 0 |
| 31 Dec 17 | 31,198 | -11,519 | 12,842 | 0 |
Quality Earnings: CARE is currently unprofitable.
Growing Profit Margin: CARE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CARE is unprofitable, and losses have increased over the past 5 years at a rate of 53.7% per year.
Accelerating Growth: Unable to compare CARE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CARE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (0.5%).
Return on Equity
High ROE: CARE has a negative Return on Equity (-3.57%), as it is currently unprofitable.